Two Issued US Patents Granted to Cellectis for CRISPR Use in T-Cells – Business Wire (press release)
Business Wire (press release) |
Two Issued US Patents Granted to Cellectis for CRISPR Use in T-Cells
Business Wire (press release) Convinced of their strong value for the future development of engineered CAR T-cells, Cellectis will make these patents available for licensing to companies that are willing to use CRISPR technologies in T-cells. The technical knowledge in these … France’s Cellectis wins US patents for gene editing technologyWHTC |
Houston Chronicle |
Viral immunotherapy extends lives of MD Anderson brain cancer patients
Houston Chronicle Baskin’s own research has produced what’s thought to be the greatest single success in brain cancer viral immunotherapy – a glioblastoma patient who has now survived 11 years.Among the patients benefitting from MD Anderson’s study was Phil Baumann, a … |
FOX 4 News |
Former Dallas Cowboys turning to stem cell treatments
FOX 4 News Some former Dallas Cowboy greats say they’re dealing with pain and injuries from the brutality of pro-football careers with stem cell treatment. The treatment they receive is not fully approved by the Food and Drug Administration so part of it is done … Consumer health alert: many stem–cell therapy claims are unprovenKOMO News Global Stem Cell Banking Market Research Key Players, Industry Overview, Supply Chain and Analysis to – 2023Austrian Tribune Future of the Global Stem Cell Source Sales Market – Growth, Latest Trend & Forecast 2022Island Post Gazette satPRnews (press release) –Financial News Review –MilTech all 32 news articles » |
FOX 4 News |
Consumer health alert: many stem–cell therapy claims are unproven
KOMO News But Consumer Reports warns a cottage industry has emerged promoting unproven stem cell treatments, which are most often not covered by insurance – everything from sexual dysfunction to arthritis, to diabetes and even COPD. “It’s so easy for consumers … Former Dallas Cowboys turning to stem cell treatmentsFOX 4 News |